Crossmark

Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression

Published Online: 2022-06-01

Published Print: 2023-03

Authors

Wang, Zheng-zheng

Li, Xiao-ting

Li, Qing-jun

Zhou, Jin-xue https://orcid.org/0000-0001-7072-2496
License Information

Text and Data Mining valid from 2022-06-01

Version of Record valid from 2022-06-01
More Information

Article History

Received: 24 May 2021

Accepted: 18 April 2022

First Online: 1 June 2022

Declarations

:

: The authors declare no conflict of interest.

: The study was approved by the Institutional Research Ethic Committee of The Affiliated Tumor Hospital of Zhengzhou University.

Document is current